New pancreatic cancer treatment improves patient outcomes Wednesday, June 20, 2018 The PRODIGE 24/CCTG PA.6 trial results suggest that this pancreatic cancer treatment regimen should become standard practice world-wide. Patients who receive this treatment after surgery are almost twice as likely to survive. https://www.youtube.com/watch?v=6mlsvC4kttI&t=57s For more information: https://www.ctg.queensu.ca/cctg_news/study-results-suggest-new-pancreatic-cancer-treatment-regimen-should-become-standard
